Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer

NCT00768664 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
69
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer